|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Net revenues | ||||
| Cost of revenues | ||||
| Gross profit | ||||
| Operating expenses: | ||||
| Professional fees and other expenses | ||||
| Franchise tax | ||||
| Selling, general and administrative expenses | ||||
| Stock compensation expenses | ||||
| Business combination expenses | ||||
| Total operating expenses | ||||
| Operating (loss)/income | ||||
| Interest income | ||||
| Change in fair value of forward purchase agreement | ||||
| Other income/(expenses): | ||||
| Interest income | ||||
| Interest expense | ||||
| Other income | ||||
| Other expense | ||||
| Gain on debt settlement, net | ||||
| Other (expense)/income, net | ||||
| Other expenses, net | ||||
| (Loss)/income before income taxes | ||||
| Provision for income tax | ||||
| Net (loss)/income | ||||
| Less: Net loss attributable to non-controlling interest | ||||
| Net (loss)/income attributable to Cycurion | ||||
| Common stock subject to possible redemption | ||||
| Common stock not subject to possible redemption | ||||
| Total net (loss)/income attributable to Cycurion | ||||
| Comprehensive (loss)/income | ||||
| (Loss)/Earnings per share: | ||||
| Basic (in dollars per share) | ||||
| Common stock subject to possible redemption | ||||
| Common stock not subject to possible redemption | ||||
| Total basic (in dollars per share) | ||||
| Diluted (in dollars per share) | ||||
| Common stock subject to possible redemption | ||||
| Common stock not subject to possible redemption | ||||
| Total diluted (in dollars per share) | ||||
| Weighted average shares outstanding: | ||||
| Basic (in shares) | ||||
| Common stock subject to possible redemption | ||||
| Common stock not subject to possible redemption | ||||
| Total basic (in shares) | ||||
| Diluted (in shares) | ||||
| Common stock subject to possible redemption | ||||
| Common stock not subject to possible redemption | ||||
| Total diluted (in shares) | ||||
Loading...